CNS Stock Analysis: Cohen & Steers | NYSE
Asset Management | NYSE, USA | Market Cap: 4.285m USD | 12M Return: 17.6% | US19247A1007 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 19.0M
EPS Trend: 85.5%
Qual. Beats: 0
Rev. Trend: 96.6%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Cohen & Steers, Inc. (NYSE: CNS) is a publicly traded asset management holding company founded in 1986 and headquartered in New York. The firm provides investment management services to institutional investors such as pension funds, endowments, and foundations, offering equity, fixed income, multi-asset, and commodity portfolios, as well as mutual funds and hedge funds launched through its subsidiaries.
The company specializes in real assets and alternative income, with a focus on real estate (including REITs), infrastructure, natural resource equities, commodities, and preferred securities. Its sector focus and product lineup in real assets differentiate it from broader diversified asset managers, and as a publicly listed asset manager (GICS: Asset Management & Custody Banks), its revenue is primarily driven by fees calculated on assets under management (AUM).
- REIT sector performance drives AUM and fee revenue
- Rising rates pressure preferred security and real estate valuations
- Net asset flows reflect demand for real asset strategies
| Net Income: 168.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.23 > 0.02 and ΔFCF/TA -8.41 > 1.0 |
| NWC/Revenue: 14.97% < 20% (prev 52.07%; Δ -37.10% < -1%) |
| CFO/TA 0.14 > 3% & CFO 127.1m > Net Income 168.3m |
| Net Debt (-477.8m) to EBITDA (229.0m): -2.09 < 3 |
| Current Ratio: 2.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (51.9m) vs 12m ago 0.76% < -2% |
| Gross Margin: 76.60% > 18% (prev 49.54%; Δ 27.07% > 0.5%) |
| Asset Turnover: 72.53% > 50% (prev 75.32%; Δ -2.79% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.10 (Total Current Assets 143.6m - Total Current Liabilities 54.0m) / Total Assets 901.0m |
| B: -0.09 (Retained Earnings -85.1m / Total Assets 901.0m) |
| C: 0.26 (EBIT TTM 218.4m / Avg Total Assets 826.0m) |
| D: 2.87 (Book Value of Equity 589.4m / Total Liabilities 205.6m) |
| Altman-Z'' = 5.13 = AAA |
| DSRI: 1.04 (Receivables 84.5m/77.0m, Revenue 599.1m/565.6m) |
| GMI: 0.65 (GM 49.54% / 76.60%) |
| AQI: 1.82 (AQ_t 0.67 / AQ_t-1 0.37) |
| SGI: 1.06 (Revenue 599.1m / 565.6m) |
| TATA: 0.05 (NI 168.3m - CFO 127.1m) / TA 901.0m) |
| Beneish M = -2.79 (Cap -4..+1) = A |
As of August 23, 2026, the stock is trading at USD 81.42 with a total of 82,974 shares traded. Over the past week, the price has changed by -3.92%, over one month by +1.59%, over three months by +13.76% and over the past year by +17.56%.
Current recommended Stop Loss: 77.50 (which is 4.8% or 1.6 ATR below the current price).
Cohen & Steers has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CNS.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 76 | -6.7% |
P/E Trailing = 26.0437
P/E Forward = 23.3645
P/S = 7.3395
P/B = 7.3934
P/EG = 2.1358
Revenue TTM = 599.1m USD
EBIT TTM = 218.4m USD
EBITDA TTM = 229.0m USD
Long Term Debt = unknown (none)
Short Term Debt = 15.4m USD (from shortTermDebt, last fiscal year)
Debt = 134.4m USD (from shortLongTermDebtTotal, last quarter) (leases 136.3m already included)
Net Debt = -477.8m USD (calculated: Debt 134.4m - CCE 612.2m)
Enterprise Value = 3.81b USD (4.29b + Debt 134.4m - CCE 612.2m)
Interest Coverage Ratio = unknown (Ebit TTM 218.4m / Interest Expense TTM 0.0)
EV/FCF = 18.23x (Enterprise Value 3.81b / FCF TTM 208.9m)
FCF Yield = 5.49% (FCF TTM 208.9m / Enterprise Value 3.81b)
FCF Margin = 34.87% (FCF TTM 208.9m / Revenue TTM 599.1m)
Net Margin = 28.09% (Net Income TTM 168.3m / Revenue TTM 599.1m)
Gross Margin = 76.60% ((Revenue TTM 599.1m - Cost of Revenue TTM 140.2m) / Revenue TTM)
Gross Margin QoQ = 88.32% (prev 85.35%)
Tobins Q-Ratio = 4.23 (Enterprise Value 3.81b / Total Assets 901.0m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 134.4m)
Taxrate = 25.52% (57.9m / 227.1m)
NOPAT = 162.7m (EBIT 218.4m * (1 - 25.52%))
Current Ratio = 2.32 (Total Current Assets 143.6m / Total Current Liabilities 61.8m)
Debt / Equity = 0.23 (Debt 134.4m / totalStockholderEquity, last quarter 589.4m)
Debt / EBITDA = -2.09 (Net Debt -477.8m / EBITDA 229.0m)
Debt / FCF = -2.29 (Net Debt -477.8m / FCF TTM 208.9m)
Total Stockholder Equity = 566.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 20.38% (Net Income 168.3m / Total Assets 901.0m)
RoE = 29.72% (Net Income TTM 168.3m / Total Stockholder Equity 566.2m)
RoCE = 25.79% (EBIT 218.4m / Capital Employed (Total Assets 901.0m - Current Liab 54.0m))
RoIC = 19.54% (NOPAT 162.7m / Invested Capital 832.5m)
WACC = 8.82% (E(4.29b)/V(4.42b) * Re(9.10%) + D(134.4m)/V(4.42b) * Rd(0.0%) * (1-Tc(0.26)))
Discount Rate = 9.10% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 75.70 | Cagr: 1.79%
[DCF] Terminal Value 71.90% ; FCFF base≈220.2m ; Y1≈198.9m ; Y5≈170.4m
[DCF] Fair Price = 58.24 (EV 2.52b - Net Debt -477.8m = Equity 2.99b / Shares 51.4m; r=8.82% [WACC]; 5y FCF grow -11.96% → 2.50% )
EPS Correlation: 85.45 | EPS CAGR: 5.17% | SUE: 0.72 | # QB: 0
Revenue Correlation: 96.59 | Revenue CAGR: 7.42% | SUE: 2.67 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.93 | Chg30d=-2.12% | Revisions=-40% | Analysts=2
EPS current Year (2026-12-31): EPS=3.53 | Chg30d=-0.19% | Revisions=+0% | GrowthEPS=+14.3% | GrowthRev=+10.6%
EPS next Year (2027-12-31): EPS=3.98 | Chg30d=+2.94% | Revisions=-17% | GrowthEPS=+12.6% | GrowthRev=+10.1%
[Analyst] Revisions Ratio: -30% (up=2, down=5)